A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers
Clinical trial NCT05737082 · COMPLETED
Trial details
- NCT number
- NCT05737082
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-30
- Primary completion
- 2023-05-14
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.